You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)

Recruiting
  • B-cell Acute Lymphocytic Leukemia
  • CD19 CAR-T cells
  • Suzhou, China
    The First Affiliated Hospital of Soochow University
Jan 11, 2023

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

Not yet recruiting
  • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 28, 2022

Metastatic Tumor, Renal Cell Carcinoma, Advanced Cancer Trial in Jinan (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +2 more
  • CD70 CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 26, 2022

Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Jinan (CEA CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +5 more
  • CEA CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jul 19, 2022

Solid Tumor, Lung Cancer, Colorectal Cancer Trial in Chongqing (CEA CAR-T cells)

Recruiting
  • Solid Tumor
  • +6 more
  • CEA CAR-T cells
  • Chongqing, Chongqing, China
  • +1 more
Sep 9, 2022

Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Neuropsychological testing
  • San Francisco, California
    Stanford Cancer Center
Nov 9, 2022

Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

Not yet recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • Anti-mesothelin CAR-T cells
  • (no location specified)
Mar 13, 2023

Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

Recruiting
  • CAR-T Therapy Complications
    • Bologna, Italy
      IRCC, University Hospital of Bologna
    Mar 18, 2022

    B-cell Non-Hodgkin's Lymphoma Trial in Shanghai (Human CD19Targeted T Cells Injection)

    Recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • Human CD19Targeted T Cells Injection
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Jun 29, 2022

    Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)

    Not yet recruiting
    • Digestive Tumor
    • TM4SF1-positive chimeric antigen receptor T-cell therapy
    • (no location specified)
    Dec 21, 2022

    T-cell Acute Lymphoblastic Leukemia Trial in Beijing (CD5 CAR-T)

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • CD5 CAR-T
    • Beijing, Beijing, China
      Xuanwu Hospital Capital Medical University
    Oct 23, 2022

    Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

    Not yet recruiting
    • Relapsed/ Refractory Multiple Myeloma
    • GC012F
    • (no location specified)
    Apr 28, 2023

    Multiple Myeloma, Relapse Multiple Myeloma Trial in Ramat Gan (CAR-BCMA)

    Recruiting
    • Multiple Myeloma
    • Relapse Multiple Myeloma
    • CAR-BCMA
    • Ramat Gan, Israel
      Chaim Sheba Medical Center, Tel Hashomer
    Feb 7, 2022

    Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

    Recruiting
    • Non-Hodgkin Lymphoma
    • Focal radiation therapy (RT)
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 8, 2022

    Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

    Recruiting
    • Malignant Neoplasm
    • +4 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • BTK inhibitor
    • PD-1 inhibitor
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    May 20, 2023

    Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

    Recruiting
    • Hematologic Malignancy
    • Blood draw
    • Durham, North Carolina
      Duke University
    Jun 22, 2022

    Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +2 more
    • Miami, Florida
      University of Miami
    Aug 3, 2022

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA CAR-T
    • VRD
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 5, 2023

    Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Jinan (CD70 CAR-T cells)

    Recruiting
    • Metastatic Tumor
    • +4 more
    • CD70 CAR-T cells
    • Jinan, Shandong, China
      The Second People's Hospital of Shandong Province
    Jun 14, 2022

    Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Hangzhou (CEA CAR-T cells)

    Recruiting
    • Colorectal Cancer
    • +5 more
    • CEA CAR-T cells
    • Hangzhou, Zhejiang, China
      First affiliated hospital, Zhejiang University
    May 30, 2022

    Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

    Not yet recruiting
    • Multiple Myeloma
    • Smoldering Multiple Myeloma
    • Ciltacabtagene Autoleucel
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 2, 2023

    Lymphoma, B-Cell Trial in Langfang (CD19 and CD22 targeted CAR-T cells)

    Not yet recruiting
    • Lymphoma, B-Cell
    • CD19 and CD22 targeted CAR-T cells
    • Langfang, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Dec 6, 2022

    Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

    Not yet recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Biospecimen Collection
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Mar 24, 2023